Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Naproxen in JRA
NCT00652925Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2002
- Primary completion
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of celecoxib in juvenile idiopathic arthritis (JIA), sponsored by Pfizer. Started Oct 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT00652925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652925.